Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Cardiologists examine how residual TR after transcatheter tricuspid valve repair impacts survival
Researchers tracked data from more than 600 patients, noting that heart teams may want to reconsider how they classify residual TR after treatment.
AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS
HeartFlow's noninvasive Plaque Analysis technology, which uses AI to evaluate CCTA images, delivered assessments that mostly lined up with IVUS results.
Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M
Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients.
FDA grants breakthrough device designation to new TMVR device from 4C Medical
The supra-annular AltaValve System was designed to treat both primary and secondary mitral regurgitation. It is implanted via transseptal access and positioned above the native mitral valve.
TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms
Researchers tracked data from more than 7,500 patients, sharing their findings at EuroPCR 2024 in Paris and in JSCAI.

Cardiologists examine how residual TR after transcatheter tricuspid valve repair impacts survival

Researchers tracked data from more than 600 patients, noting that heart teams may want to reconsider how they classify residual TR after treatment.

May 16, 2024

HeartFlow Plaque Analysis. A European Heart Journal – Cardiovascular Imaging study compared the noninvasive Plaque Analysis technology developed by HeartFlow, which uses advanced AI algorithms to evaluate coronary CT angiography (CCTA) images, with coronary plaque assessments achieved by using intravascular ultrasound (IVUS). The REVEALPLAQUE trial included data from 237 patients. Plaque Analysis showed strong correlation and high accuracy when compared with IVUS.

AI-powered coronary plaque assessments show ‘strong agreement’ with IVUS

HeartFlow's noninvasive Plaque Analysis technology, which uses AI to evaluate CCTA images, delivered assessments that mostly lined up with IVUS results.

May 16, 2024

Atraverse Medical Hotwire radiofrequency (RF) guidewire. Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients.

Medical device startup gains FDA clearance for new RF guidewire, raises $12.5M

Atraverse Medical, a San Diego-based medical device company founded in 2022, designed the guidewire to give physicians as much freedom as possible while treating heart patients.

May 16, 2024

FDA grants breakthrough device designation to new TMVR device from 4C Medical

The supra-annular AltaValve System was designed to treat both primary and secondary mitral regurgitation. It is implanted via transseptal access and positioned above the native mitral valve.

May 15, 2024

Cardiologist Heart Doctor Tablet Technology

TAVR, SAVR linked to comparable long-term outcomes, new meta-analysis confirms

Researchers tracked data from more than 7,500 patients, sharing their findings at EuroPCR 2024 in Paris and in JSCAI.

May 15, 2024

FDA announces another new recall involving Abbott’s HeartMate 3 LVADs after 70 injuries, 2 deaths

Abbott issued the new recall after receiving more than 80 reports of blood or air entering the LVAD during implant procedures. Customers can still use these devices, but they are advised to follow specific steps to limit the risk of complications.

May 15, 2024

Salt substitutes are associated with a reduced risk of high blood pressure without increasing the risk of low blood pressure, according to new findings published in the Journal of the American College of Cardiology.[1]

World Health Organization urges countries to limit salt intake to reduce risk of CVD, hypertension

The group wants countries to implement population-wide changes that can keep salt intake to a minimum. It estimates that such policies could save up to 900,000 lives in just a few years.

May 15, 2024

Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension

The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms.

May 14, 2024

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."